Levocetirizine Hydrochloride Tablets 5mg (Xyzal® / ザイザル錠5mg)

JPY ¥4,200

Japanese sustained-action selective H1 receptor antagonist / antiallergic agent (Levocetirizine Hydrochloride 5mg). Oral tablet for allergic rhinitis and urticaria in adults and pediatric patients. 100 tablets [10 tablets (PTP) x 10]. Mfd. by GlaxoSmithKline K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥3,864
10 - 19 12% JPY ¥3,696
20 + 18% JPY ¥3,444
SKU: XYZ-5-TAB Category:

Description

Product Overview / 商品概要

Xyzal Tablets 5mg (ザイザル錠5mg)
Generic: Levocetirizine Hydrochloride / レボセチリジン塩酸塩
Therapeutic Category: Sustained-action selective H1 receptor antagonist / Antiallergic agent / 持続性選択H1受容体拮抗・アレルギー性疾患治療剤
Manufactured by: GlaxoSmithKline K.K. / グラクソ・スミスクライン株式会社

Composition & Specification / 組成・規格

Active Ingredient: Levocetirizine Hydrochloride 5mg per tablet / 1錠中 レボセチリジン塩酸塩5mg
Additives: Microcrystalline cellulose, Light anhydrous silicic acid, Lactose hydrate, Magnesium stearate, Hypromellose, Titanium oxide, Macrogol 400 / 結晶セルロース、軽質無水ケイ酸、乳糖水和物、ステアリン酸マグネシウム、ヒプロメロース、酸化チタン、マクロゴール400
Appearance: White film-coated tablet with bisect score on both sides; identification code: XX; dimensions: 8mm x 4.5mm; thickness: 3.2mm; weight: 103mg
外観: 白色の両面割線入りのフィルムコーティング錠、識別コード:XX、長径×短径:8mm×4.5mm、厚さ:3.2mm、質量:103mg

Indications / 効能効果

EN: [Adults] Allergic rhinitis; Urticaria; Eczema/dermatitis; Prurigo; Pruritus cutaneus. [Pediatric] Allergic rhinitis; Pruritus associated with urticaria and skin disorders (eczema/dermatitis, pruritus cutaneus)
JA: 【成人】アレルギー性鼻炎、蕁麻疹、湿疹・皮膚炎、痒疹、皮膚そう痒症【小児】アレルギー性鼻炎、蕁麻疹、皮膚疾患(湿疹・皮膚炎、皮膚そう痒症)に伴うそう痒

Dosage and Administration / 用法用量

EN: [Adults] Levocetirizine hydrochloride 5mg orally once daily at bedtime. Dose may be adjusted according to age and symptoms; maximum daily dose is 10mg. [Pediatric] For children aged 7 to under 15 years: levocetirizine hydrochloride 2.5mg orally twice daily, after breakfast and at bedtime.
JA: 【成人】通常、成人にはレボセチリジン塩酸塩として1回5mgを1日1回、就寝前に経口投与する。なお、年齢、症状により適宜増減するが、最高投与量は1日10mgとする。【小児】通常、7歳以上15歳未満の小児にはレボセチリジン塩酸塩として1回2.5mgを1日2回、朝食後及び就寝前に経口投与する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product or piperazine derivatives (including cetirizine and hydroxyzine); Patients with severe renal impairment (creatinine clearance less than 10 mL/min)
JA: 本剤の成分又はピペラジン誘導体(セチリジン、ヒドロキシジンを含む)に対し過敏症の既往歴のある患者;重度の腎障害(クレアチニンクリアランス10mL/min未満)のある患者

Regulatory Information / 規制情報

Approval No.: 22200AMX00949
Sales Started: December 2010 / 2010年12月
Classification Code: 87449
Storage: Store at room temperature / 室温保存
Shelf Life: 5 years / 5年

Packaging / 包装

Main Package (for sale): 100 tablets [10 tablets (PTP) x 10] / 100錠[10錠(PTP)×10]
Other Available Packages (by special order): 100 tablets [10 tablets (PTP) x 10]; 500 tablets [10 tablets (PTP) x 50]

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Levocetirizine Hydrochloride Tablets 5mg (Xyzal® / ザイザル錠5mg)”

メールアドレスが公開されることはありません。 が付いている欄は必須項目です

Export from Japan — Levocetirizine Hydrochloride Tablets 5mg (Xyzal®

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.